Helping you understand the power of AI in healthcare market research.
At Research Partnership, we want to empower our experts to optimize their strategic capability, providing insights that have a lasting impact on you and the patients you serve. We continue to discover, build, implement and share the most effective applications of human and artificial intelligence (AI) engagements through agile and responsible experimentation.
With the intelligence of our people, we can help unlock the commercial value of AI and incorporate appropriate tools into the execution of our market research projects, the delivery of insights and in driving tangible outcomes in our client businesses, helping to navigate confident decision-making.
We understand that AI has the ability to be transformative, with an untapped ability to work even smarter for strategic decision making in pharmaceuticals.
Powered by our people, we want to leverage the best that AI has to offer, to:
Our AI in market research webcast explores, how we are applying the latest AI tools to enhance our services and the value they can bring our client organisations, including industry concerns around data privacy and safety.
We’re bringing the best of AI to our practices through rigorous experimentation. We ensure that the tools we use are fit for purpose and meet the standards required by our clients in terms of data privacy and compliance.
Our Innovation Centre is championed by our internal steering committee of creative, progressive, and experienced pioneers, aims to foster a highly innovative company culture and strengthen our industry leadership.
The program encourages employees from across our offices to work together in a collaborative and creative environment to develop commercially viable, innovative techniques and methodologies that expand the range of products and services we can offer to our clients.
Find out more about our Innovation Centre of Expertise.
Find out how we provided our client with a deeper understanding of genuine HCP/patient interactions using AI avatars
Paul Reed and Annabelle Gall consider the benefits and drawbacks of using AI with regards to diversity and synthetic patients in market research.
How we explored the opportunity for an existing auto-immune product to be used in the treatment of another more low-prevalence orphan disease.
Across Inizio Advisory, we’re helping you navigate with certainty through connected capabilities in market research, consulting, and brand measurement, combined with our AI powered technology platforms and data-driven insights.
Looking to integrate AI into your next market research project?
